Early Access — free while we kick the tires
EdgarHawk

Lettmann Jason

CHIEF EXECUTIVE OFFICER

Director Officer
1 filing analyzed · 1 company · Latest 2025-09-18

Companies

Company Buys Sells Direction
ALX ONCOLOGY HOLDINGS INC ALXO 2 0 Net buying

Activity

September 2025
high
Buy
92,233 shares
$99,352
Significance 6/10

ALXO CEO Jason Lettmann bought 92,233 shares (avg $1.08) on 2025-09-16/17; holdings +43.3% to 305.1K shares.

CEO Jason Lettmann purchased 92,233 shares across two separate transactions totaling $99,352.24 at an average price of $1.08, increasing his holdings by 43.3% to 305,121 shares. The company is unprofitable with net income of $-25,949,000.00 over its most recent full fiscal year and reported only $527,000.00 in revenue in the latest quarter, creating a notable mismatch between the scale of insider accumulation and the company's financial profile. Lettmann's prior buy at ALXO on 2024-03-14 returned -24.6% over 90 days, and his cross-ticker track record shows a 0.00% win rate across 90-day periods, suggesting a pattern of poorly-timed buys. The current stock price of $1.09 is -50.9% from its 52-week high and the recent 30-day surge of +22.5% immediately preceding this purchase may warrant scrutiny into the motivations and timing of this substantial equity commitment.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access